• OPEN AN ACCOUNT
Indian Indices
Sensex
73,480.01 -229.68
( -0.31%)
Global Indices
Nasdaq
52,880.09 363.21
(0.69%)
Dow Jones
7,780.08 46.51
(0.60%)
Hang Seng
64,728.80 653.38
(1.02%)
Nikkei 225
10,751.68 18.68
(0.17%)
Forex
USD-INR
94.82 -0.08
(-0.09%)
EUR-INR
106.45 0.01
(0.01%)
GBP-INR
126.63 0.25
(0.20%)
JPY-INR
0.60 0.00
(-0.04%)

EQUITY - MARKET SCREENER

Industry :  
BSE Code
ISIN Demat
Book Value()
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
EPS(TTM)
Face Value()
Div & Yield %
 

Strides Pharma Science consolidated net profit rises 57.52% in the June 2026 quarter
Jul 31,2026
Net profit of Strides Pharma Science rose 57.52% to Rs 156.91 crore in the quarter ended June 2026 as against Rs 99.61 crore during the previous quarter ended June 2025. Sales rose 13.01% to Rs 1265.41 crore in the quarter ended June 2026 as against Rs 1119.74 crore during the previous quarter ended June 2025.

ParticularsQuarter Ended
Jun. 2026Jun. 2025% Var.
Sales1265.411119.74 13
OPM %18.0619.48 -
PBDT192.82179.30 8
PBT136.42130.41 5
NP156.9199.61 58